For the state, the cost of funding obesity medications was too high. For the patients, the cost of losing access is higher.

Taking a break from weight-loss medication over the holidays might seem like a small decision, but it can have lasting ...

Struggles with obesity are a longstanding issue for millions of Americans and thousands of Iowans, but recent advancements in ...

Elon Musk validated the use of GLP-1 drugs in a post on X on Wednesday. But Robert F. Kennedy Jr. has said he's opposed to ...

Randomised controlled trials and real word evidence have consistently shown that GLP-1 receptor agonists are effective and ...

Wegovy and other GLP-1 medications have become extremely popular over the past few years. Novo Nordisk (which makes both ...

Elon Musk, the richest person alive and the co-head of President-elect Donald Trump’s new Department of Government Efficiency ...

Novo Nordisk parent’s huge manufacturing deal is one step closer to closing. Meanwhile, Nobel Prize winners urge senators to ...

A recent New York Times story described a new fad: "microdosing" GLP-1 anti-obesity drugs like semaglutide (Ozempic, Wegovy) ...

For the 15.5 million U.S. adults on GLP-1 medications like Ozempic and Wegovy, holiday meals can pose a challenge. Melanie ...

Here are 10 major orthopedic studies conducted in 2024 to know: ...